Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, Le Garff-Tavernier M, Bougacha N, Struski S, Bidet A, Laharanne E, Barin C, Veronese L, Prié N, Eclache V, Gaillard B, Michaux L, Lefebvre C, Gaillard JB, Terré C, Penther D, Bastard C, Nadal N, Fert-Ferrer S, Auger N, Godon C, Sutton L, Tournilhac O, Susin SA, Nguyen-Khac F; GroupeFrancophone de Cytogénétique Hématologique(GFCH) and the French Innovative Leukemia Organization (FILO) group. Chapiro E, et al. Among authors: bouzy s. Am J Hematol. 2018 Mar;93(3):375-382. doi: 10.1002/ajh.24990. Epub 2017 Dec 18. Am J Hematol. 2018. PMID: 29194741 Free article.
Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug-resistant chronic lymphocytic leukemia.
Kostopoulou F, Gabillaud C, Chapiro E, Grange B, Tran J, Bouzy S, Degaud M, Ghamlouch H, Le Garff-Tavernier M, Maloum K, Choquet S, Leblond V, Gabarre J, Lavaud A, Morel V, Roos-Weil D, Uzunov M, Guieze R, Bernard OA, Susin SA, Tournilhac O, Nguyen-Khac F; French Innovative Leukemia Organization (FILO) group. Kostopoulou F, et al. Among authors: bouzy s. Cancer Med. 2019 Jun;8(6):3131-3141. doi: 10.1002/cam4.2123. Epub 2019 May 7. Cancer Med. 2019. PMID: 31066214 Free PMC article.
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Chapiro E, Pramil E, Diop M, Roos-Weil D, Dillard C, Gabillaud C, Maloum K, Settegrana C, Baseggio L, Lesesve JF, Yon M, Jondreville L, Lesty C, Davi F, Le Garff-Tavernier M, Droin N, Dessen P, Algrin C, Leblond V, Gabarre J, Bouzy S, Eclache V, Gaillard B, Callet-Bauchu E, Muller M, Lefebvre C, Nadal N, Ittel A, Struski S, Collonge-Rame MA, Quilichini B, Fert-Ferrer S, Auger N, Radford-Weiss I, Wagner L, Scheinost S, Zenz T, Susin SA, Bernard OA, Nguyen-Khac F; the Groupe Francophone de Cytogénétique Hématologique (GFCH); the French Innovative Leukemia Organization (FILO). Chapiro E, et al. Among authors: bouzy s. Blood. 2019 Nov 21;134(21):1821-1831. doi: 10.1182/blood.2019001187. Blood. 2019. PMID: 31527074 Free article.
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia.
Joudinaud R, Boudry A, Fenwarth L, Geffroy S, Salson M, Dombret H, Berthon C, Pigneux A, Lebon D, Peterlin P, Bouzy S, Flandrin-Gresta P, Tavernier E, Carre M, Tondeur S, Haddaoui L, Itzykson R, Bertoli S, Bidet A, Delabesse E, Hunault M, Récher C, Preudhomme C, Duployez N, Dumas PY. Joudinaud R, et al. Among authors: bouzy s. Blood Adv. 2025 Jan 28;9(2):365-374. doi: 10.1182/bloodadvances.2024014672. Blood Adv. 2025. PMID: 39418643
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.
De Almeida Braga C, Bauvais M, Sujobert P, Heiblig M, Jullien M, Le Calvez B, Richard C, Le Roc'h V, Rault E, Hérault O, Peterlin P, Garnier A, Chevallier P, Bouzy S, Le Bris Y, Néel A, Graveleau J, Kosmider O, Paul-Gilloteaux P, Normand N, Eveillard M. De Almeida Braga C, et al. Among authors: bouzy s. Int J Lab Hematol. 2025 Feb;47(1):120-129. doi: 10.1111/ijlh.14368. Epub 2024 Sep 14. Int J Lab Hematol. 2025. PMID: 39275905
Neonatal diagnosis of congenital dyserythropoietic anemia type II.
Lelard A, Le Calvez B, Bouzy S, Couec ML, Eveillard M. Lelard A, et al. Among authors: bouzy s. Int J Lab Hematol. 2024 Oct;46(5):764-765. doi: 10.1111/ijlh.14265. Epub 2024 Mar 13. Int J Lab Hematol. 2024. PMID: 38477083 No abstract available.
Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a genomic profile distinct from that of γδ T-cell large granular lymphocytic leukemia.
Desmares A, Bouzy S, Thonier F, Goustille J, Llamas-Gutierrez F, Genevieve F, Cottin L, Baseggio L, Lemaire P, Lafon CL, Cornillet-Lefebvre P, Galoisy AC, Brouzes C, Rault E, Dindinaud E, Fleury C, Blanc-Jouvan F, Wuilleme S, Bardet V, Fest T, Lamy T, Roussel M, Pannetier M, Pastoret C. Desmares A, et al. Among authors: bouzy s. Haematologica. 2024 Jun 1;109(6):1941-1946. doi: 10.3324/haematol.2023.283856. Haematologica. 2024. PMID: 38268478 Free PMC article. No abstract available.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Jullien M, Guillaume T, Le Bourgeois A, Peterlin P, Garnier A, Eveillard M, Le Bris Y, Bouzy S, Tessoulin B, Gastinne T, Dubruille V, Touzeau C, Mahé B, Blin N, Lok A, Vantyghem S, Sortais C, Antier C, Moreau P, Scotet E, Béné MC, Chevallier P. Jullien M, et al. Among authors: bouzy s. Am J Hematol. 2024 Mar;99(3):350-359. doi: 10.1002/ajh.27191. Epub 2024 Jan 2. Am J Hematol. 2024. PMID: 38165016 Clinical Trial.
12 results